Panahi Y, Azizi T, Moghadam MRS, Amin G, Parvin S, Sahebkar A. Oral health
status among Iranian veterans exposed to sulfur mustard: A case-control study. J Clin Exp Dent. 2015;7(2):e192-6.
doi:10.4317/jced.52112
References
1. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM. Mustard gas toxicity: the acute and chronic
pathological effects. J Appl Toxicol.
2010;30:627-43. |
|
|
|
2. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines
D. Incidence of lung, eye, and skin lesions as late complications in 34000
Iranians with wartime exposure to mustard agent. J Occup
Environ Med. 2003;45:1136-43. |
|
|
|
3. Somani SM, Babu SR. Toxicodynamics of sulfur mustard. Int
J Clin Pharmacol Ther Toxicol. 1989;27:419-35 |
|
|
|
4. Karimi Zarchi AA, Holakouie Naieni K. Long-term
pulmonary complications in combatants exposed to mustard gas: a historical
cohort study. Int J Epidemiol. 2004;33:579-81. |
|
|
|
5. Wattana M, Bey T. Mustard gas
or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp Disaster Med. 2009;24:19-29. |
|
|
|
6. Weiss A,
Weiss B. Carcinogenesis due to mustard gas exposure in man, important sign
for therapy with alkylating agents. Dtsch Med Wochenschr. 1975;100:919-23. |
|
|
|
7. Ghanei M, Vossoughi AA, Fahim A, Adibi P. A Study of
Chronic Hematologic Complications of Chemical Veterans and Blood Cells Time
Course Poisoning. Kowsar Medical Journal. 2009;5:195-8. |
|
|
|
8. Ghotbi L, Hassan Z. The immunostatus
of natural killer cells in people exposed to sulfur mustard. Int Immunopharmacol. 2002;2:981-5. |
|
|
|
9. Balali-Mood M, Hefazi M. The
pharmacology, toxicology, and medical treatment of sulphur
mustard poisoning. Fundam Clin
Pharmacol. 2005;19:297-315. |
|
|
|
10. Zafarghandi MR, Soroush MR, Mahmoodi M, Naieni KH, Ardalan A, Dolatyari A, et al.
Incidence of cancer in Iranian sulfur mustard exposed veterans: a long-term
follow-up cohort study. Cancer Causes Control. 2013;24:99-105. |
|
|
|
11. Manning
KP, Skegg DC, Stell PM,
Doll R. Cancer of the larynx and other occupational hazards of mustard gas
workers. Clin Otolaryngol
Allied Sci. 1981;6:165-70. |
|
|
|
12. Hirono M, Suehiro S, Hirai T, Niimoto M, Hattori T. Early gastric cancer with
widespread lymph node metastases; a case report. Jpn J Surg.
1984;14:143-5. |
|
|
|
13. Ghanei M, Vosoghi AA. An
epidemiologic study to screen for chronic myelocytic
leukemia in war victims exposed to mustard gas. Environ Health Perspect. 2002;110:519-21. |
|
|
|
14.
Available at: http://www.paho.org/hq/dmdocuments/2009/OH_st_Esurv.pdf . Last accessed on Nov 05, 2014. |
|
|
|
15. Vellappally S, Fiala Z, Smejkalová J, Jacob V, Somanathan R. Smoking related systemic and oral
diseases. Acta Medica (Hradec Kralove). 2007;50:161-6. PMid:18254267 |
|
|
|
16. Soysa NS, Ellepola AN. The
impact of cigarette/tobacco smoking on oral candidosis:
an overview. Oral Dis. 2005;
11:268-73 |
|
|
|
17. Keramati MR, Balali-Mood M, Mousavi SR, Sadeghi M, Riahi-Zanjani B. Biochemical and hematological findings
of Khorasan veterans 23 years after sulfur mustard
exposure. J Res Med Sci. 2013;18:855-9. |
|
|
|
18. Shams
J, Ghazanfari T, Yaraee
R, Mahdavi MRV, Soroush
MR, Hassan ZM, et al. Long-term hematological consequences of sulfur mustard on civilians of
Sardasht 20 years after exposure. Toxin Rev.
2009;28:39-43. |
|
|
|
19. Hassan
ZM, Ebtekar M. Immunological consequence of sulfur
mustard exposure. Immunol Lett. 2002;83:151-2. PMid:12095704 |
|
|
|
20. Balali-Mood M, Mousavi SH, Balali-Mood B. Chronic health effects of sulphur mustard exposure with special reference to
Iranian veterans. Emerg Health Threats J. 2008;1:e7. PMid:22460216 |
|
|
|
21. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard
poisoning in the skin and the immune system of Iranian veterans 16-20 years
after exposure. Int J Dermatol.
2006;45:1025-31. |
|
|
|
22. Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M.
Long-term hematological and immunological complications of sulfur mustard
poisoning in Iranian veterans. Int Immunopharmacol.
2005;5:1479-85. |